Pontuação de confiança 8/100
Dr Saad Rassam
👤 7 anos de experiência
6,834+
Patients seen
7
Years in practice
5
Publications
2
Languages spoken
Sobre
Dr Rassam Qualified in 1980 from the University of Baghdad. In 1986 he arrived to the UK on a scholarship for post-graduate training in haematology. He trained as a Registrar at the Royal Free Hospital, London and Edgware General Hospital and a Senior Registrar and University of London Lecturer at St Bartholomew's Hospital, University College Hospital and Hospital for Sick Children at Great Ormond Street. During his time as a senior registrar, he conducted research into immune reconstitution following stem cell transplantation in children with severe combined immune deficiency. He received his Membership of the Royal College of Physicians and the Royal College of Pathologists in 1989 and 1992 respectively and was elected as Fellow of both colleges in 1997 and 1999.
Dr Rassam has a special interest in the management of lymphoid malignancies and in research into the immune mechanisms and therapy of cancer. In 1997 he was awarded The Microscopical Society of Great Britain and Ireland Fellowship to study the technology and isolation of tumour infiltrating lymphocytes (the immune cells against cancer) at Harvard University in the USA. Following his return, he established a research laboratory at Queen Mary's Hospital to study the role of the immune system in lymphatic cancer. He later received grants to extend his research in non-Hodgkin lymphoma at the Rayne Institute in London with novel findings. He has presented his findings in National and International meetings.
Dr. Rassam was an active member of the low and high grade lymphoma subgroups of the National Cancer Research Institute (NCRI), the British Society of Haematology, the American Society of Haematology, The UK Waldenstroms Macroglobulinaemia Group and an author on the British Society of Haematology Guidelines in Waldenstrom's Macroglobulinaemia. He was an examiner and appointment advisory officer for the Royal College of Pathologists. He is the author of a number of National clinical trial proposals. He was also the chairman of the Hemato-Oncology Group in the Kent Cancer Network and responsible for updating the lymphoma and chronic lymphocytic leukaemia (CLL) pathways. He was the National Chief Investigator for the ASCEND study in CLL.
Diseases, Medical Tests and Treatments
Immunotherapy, Chemotherapy
General Haematology
Haematological oncology
Lymphoma: Hodgkin and non-Hodgkin
Myeloma and amyloid disease
Leukaemia
Myelodysplastic Syndromes
Dr Rassam has a special interest in the management of lymphoid malignancies and in research into the immune mechanisms and therapy of cancer. In 1997 he was awarded The Microscopical Society of Great Britain and Ireland Fellowship to study the technology and isolation of tumour infiltrating lymphocytes (the immune cells against cancer) at Harvard University in the USA. Following his return, he established a research laboratory at Queen Mary's Hospital to study the role of the immune system in lymphatic cancer. He later received grants to extend his research in non-Hodgkin lymphoma at the Rayne Institute in London with novel findings. He has presented his findings in National and International meetings.
Dr. Rassam was an active member of the low and high grade lymphoma subgroups of the National Cancer Research Institute (NCRI), the British Society of Haematology, the American Society of Haematology, The UK Waldenstroms Macroglobulinaemia Group and an author on the British Society of Haematology Guidelines in Waldenstrom's Macroglobulinaemia. He was an examiner and appointment advisory officer for the Royal College of Pathologists. He is the author of a number of National clinical trial proposals. He was also the chairman of the Hemato-Oncology Group in the Kent Cancer Network and responsible for updating the lymphoma and chronic lymphocytic leukaemia (CLL) pathways. He was the National Chief Investigator for the ASCEND study in CLL.
Diseases, Medical Tests and Treatments
Immunotherapy, Chemotherapy
General Haematology
Haematological oncology
Lymphoma: Hodgkin and non-Hodgkin
Myeloma and amyloid disease
Leukaemia
Myelodysplastic Syndromes
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Saad Rassam
Educação e formação
-
2009–2015 MD · Medicine and Surgery
-
2015–2019 Residency · Hematologia
-
2019–2020 Fellowship · Subspecialty training
Carreira e nomeações
-
2019-09–2020-08 Junior consultant
Licenças e seguros
Licenças médicas
GB — Organización Médica Colegial de España (OMC)
Certificações do conselho
European Board of Hematologia
Seguro de responsabilidade profissional:
Generali Healthcare · 1,000,000 EUR cobertura · No claims on file
Procedimentos realizados
| Procedimento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 1,285 |
| Annual physical exam | 99395 | 2,419 |
| Vaccination administration | 90471 | 2,123 |
| Minor procedure (skin) | 17110 | 1,620 |
Serviços e preços
| Serviço | Duração | Modalidade | Preço |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Consultório, equipa e na prática
Vídeos
Investigação e publicações
índice h: 8 · i10: 8
-
European registry analysis of Hematologia outcomes
DOI: 10.9900/euroclin.2025.0 · PMID: 35425709 · citado por 101
-
Outcomes of Hematologia in adults — a multi-centre cohort
DOI: 10.8427/euroclin.2024.1 · PMID: 34264203 · citado por 111
-
European registry analysis of Hematologia outcomes
DOI: 10.7055/euroclin.2023.2 · PMID: 39634883 · citado por 129
Palestras convidadas
- Practical updates in Hematologia European Annual Congress (Hematologia) · Vienna · 2024 · invited
- Single-centre experience in Hematologia National Society Meeting · London · 2023 · oral abstract
Prémios e afiliações
Prémios
- 🏆 Top-rated Hematologia — London · EuroClinics Patient Choice · 2025 · regional
Filiações em sociedades
- WONCA Europe — Family Doctors — Member · Desde 2020
- national college of family doctors — Member · Desde 2020
- European Union of Medical Specialists (UEMS) — Member · Desde 2020
Artigos deste médico
- Patient education Patient guide to Hematologia
- Awareness When should you see a hematologia?
Para pacientes internacionais
- Coordenador
- Patient liaison · dr.saad.rassam@euroclinics.example
Localização
1 etiquetaAvaliações dos pacientes
Partilhe a sua experiência — ajude outros pacientes a encontrar o médico certo. Escrever uma avaliação →
Avaliações recentes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.